victoria Indenbaum

Chaim Sheba Medical Center - Central Virology Laboratory

Ramat-Gan

Israel

SCHOLARLY PAPERS

3

DOWNLOADS

490

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (3)

1.

BNT162b2 Vaccine-Induced Immune Responses and Dynamics Vary Among Age Groups, Sex and Co-Morbidities: A Longitudinal Prospective Cohort Study

Number of pages: 25 Posted: 04 Mar 2021
Chaim Sheba Medical Center - Central Virology Laboratory, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv University - Sackler Faculty of Medicine, Chaim Sheba Medical Center - Infection Prevention & Control Unit, Bio-statistical and Bio-mathematical Unit, The Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Center, Bio-statistical and Bio-mathematical Unit, The Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Center, Chaim Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center - Laboratory Division, Sheba Medical Center - Clinical Microbiology, Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center - Bio-statistical and Bio-mathematical Unit, Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center - Bio-statistical and Bio-mathematical Unit, Sheba Medical Center - Gertner Institute for Epidemiology and Health Policy Research and Chaim Sheba Medical Center - General Management
Downloads 243 (172,019)

Abstract:

Loading...

2.

Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine in People Living with HIV-1

Number of pages: 14 Posted: 20 Apr 2021
Chaim Sheba Medical Center - Infectious Diseases Unit, Chaim Sheba Medical Center - Infectious Diseases Unit, Chaim Sheba Medical Center - Infectious Diseases Unit, Chaim Sheba Medical Center - Infectious Diseases Unit, Chaim Sheba Medical Center - Central Virology Laboratory, Bio-statistical and Bio-mathematical Unit, The Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Center, Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center, Chaim Sheba Medical Center - Infectious Diseases Unit, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv University - Sackler Faculty of Medicine, Chaim Sheba Medical Center - Infection Prevention & Control Unit, Chaim Sheba Medical Center - Central Virology Laboratory and Chaim Sheba Medical Center - Infectious Diseases Unit
Downloads 238 (175,551)
Citation 2

Abstract:

Loading...

3.

Robust Antibody Response after a Third BNT162b2 Vaccine Compared to the Second Among Immunocompromised and Healthy Individuals, a Prospective Longitudinal Cohort Study

JVAC-D-22-00644
Number of pages: 30 Posted: 19 Mar 2022
Maccabi HealthCare Services, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Chaim Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center - Central Virology Laboratory, affiliation not provided to SSRN, affiliation not provided to SSRN and Maccabi HealthCare Services
Downloads 9 (776,075)

Abstract:

Loading...

BNT162b2 vaccine, COVID-19, humoral response, third vaccine dose, booster, immunocompromised